This page contains recent news articles, when available, and an overview of but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Background information on

LOUISVILLE, CO--(Marketwire - March 25, 2008) - GlobeImmune, Inc ...  -  25 Mar 2008
Market Wire (press release)The Company's lead infectious disease candidate, GI-5005, is a Tarmogen being developed for the treatment of chronic hepatitis C infection.

Korean firm to test new hepatitis  -  25 Mar 2008
Korea.net,Green Cross said it planned to use Hepabig-Gene on patients that received liver transplants and those suffering from chronic hepatitis B. The company said

GlobeImmune Announces Initiation of a Phase 2a Clinical Trial of ...  -  25 Mar 2008
PR-USA.net (press release),The Company's lead infectious disease candidate, GI-5005, is a Tarmogen being developed for the treatment of chronic hepatitis C infection.

Bristol-Myers: Baraclude Data In Line With Prior Findings  -  Mar 24, 2008
CNNMoney.com...(BMY) reported new Baraclude data demonstrated a continued low incidence of resistance in nucleoside-naive chronic hepatitis B patients through five years

Gilead's Viread wins EU backing for hepatitis B  -  Mar 20, 2008
ReutersChronic hepatitis B is caused by the hepatitis B virus, which is up to 100 times more easily transmitted than HIV. (Reporting by Ben Hirschler;

Gilead: European committee issues positive opinion on Viread for ...  -  Mar 19, 2008
CNNMoney.comViread represents Gilead's second once-daily antiviral developed for the potential treatment of chronic hepatitis B. Gilead also said it has submitted

Investigations Continue In Hepatitis Scare  -  Mar 20, 2008
KLAS-TV,And chronic hepatitis. "You could have a low level of disease, where you're getting a low level of liver damage or just a little amount of liver damage and

Pak prisoner died of hepatitis: Report  -  Mar 20, 2008
Chandigarh Newsline,...the internal inquiry by jail officials and magisterial probe had established that Khalid Mehmood, alias Azad, died due to chronic hepatitis and rupture

European CHMP Issues Positive Opinion for Viread Â® for the ...  -  Mar 19, 2008
Business Wire (press release),Viread represents Gileadâ€™s second once-daily antiviral developed for the potential treatment of chronic hepatitis B. The active ingredient in Viread,

Widow vows to fight soldier's last battle  -  Mar 22, 2008
Times Herald-Record,About 20 percent of people with chronic Hepatitis C will develop cirrhosis after 10 to 20 years, and a small number will go on to develop liver cancer,

FDA issues alert about HIV drug Prezista  -  Mar 24, 2008
United Press InternationalPatients with chronic hepatitis B or C or those who have pretreatment elevations of liver function tests should be monitored more frequently.

GlaxoSmithKline Donation Helps Protect Canadian Olympians Against ...  -  Mar 19, 2008
Canada NewsWire (press release),...(7) Up to 5 per cent of infected adults progress to chronic hepatitis B and this potentially lifelong infection can lead to cirrhosis of the liver,

Committee for Medicinal Products for Human Use Post-authorisation ...  -  Mar 21, 2008
PharmaLive.com (press release),Hepatitis B infection: Viread is indicated for the treatment of chronic hepatitis B in adults with compensated liver disease, with evidence of active viral

Caring Ambassadors Hepatitis C Program Launches Internet-Based Hep ...  -  Mar 11, 2008
Market Wire (press release)...is available to prevent chronic hepatitis C but medications are available to clear the hepatitis C virus from the body in up to 50% of people treated.

Liver Injury Linked to Darunavir (Prezista)  -  Mar 21, 2008
MedPage Today,Acute hepatitis with elevated liver enzymes in a patient co-infected with chronic hepatitis B. The condition abated when darunavir and other antiretrovirals

Taming A Vicious Silent Killer - Hepatitis B Virus (Hbv) Infection  -  Mar 7, 2008
Nigerian Tribune,Overall, chronic hepatitis progresses to end stage liver disease in 15-40% of patients. The global occurrence of HBV infection is traditionally described

Hepatitis - C: A silent killer  -  Mar 4, 2008
Central Chronicle,No vaccine is currently available to prevent hepatitis C and treatment for chronic hepatitis C is too costly for most persons in developing countries to

Hepatitis B: The silent killer  -  Mar 1, 2008
The New Nation,Symptoms of acute and chronic Hepatitis B differ from each other. Children and young kids usually does not manifest significant symptoms, but in some cases

Feeling liverish? Maybe it's your liver  -  Mar 17, 2008
Shanghai Daily,Chronic hepatitis sufferers should be especially vigilant in spring because the general may need reinforcements, writes Zhang Qian. Nature revives in spring

Insulin resistance tied to hepatitis C infection  -  Feb 27, 2008
Reuters India,By Michelle Rizzo NEW YORK (Reuters Health) - Insulin resistance, a "prediabetic" abnormality of blood sugar, is a specific feature of chronic hepatitis C

Hepatitis B Foundation Testifies Before Congressional ...  -  Mar 20, 2008
PR Newswire (press release),March 20 /PRNewswire-USNewswire/ -- Hepatitis B Foundation President Dr. Timothy Block testified about the public health challenge of chronic hepatitis

Biomarker Panel May Improve Disease Staging in Chronic HCV  -  Mar 5, 2008
MedPage Today,Explain to interested patients that people with chronic hepatitis C are at risk of cirrhosis and other complications, including liver cancer.

Gilead Sciences Says European CHMP Issues Positive Opinion For ...  -  Mar 19, 2008
RTT News,...the company's application to extend the indication for Viread (tenofovir disoproxil fumarate) to include the treatment of chronic hepatitis B in adults.

China gene experts search for answers on diabetes  -  Feb 26, 2008
Tehran Times,Chronic Hepatitis B affects 360 million people globally, and of these, 281 million are in Asia. One in four will die from either cirrhosis, or scarring of

Treatment of the HBV-Infected Patient: When to Start, When to Stop ...  -  Feb 27, 2008
Medscape (subscription)Chronic hepatitis B virus (HBV) infection is a potentially serious disease that can lead to cirrhosis, end-stage liver disease, and hepatocellular carcinoma

Nayar notice on death of Khalid  -  Mar 24, 2008
Howrah News Service,..."The internal inquiry by jail officials and magisterial probe have established that Khalid Mehmood, alias Azad, died due to chronic hepatitis and rupture of

Liver Cancer â€“ Signs and Symptoms of Liver Cancer  -  Mar 17, 2008
Los Angeles Chronicle,Worsened hepatitis or cirrhosis symptoms - More severe symptoms in people who have chronic hepatitis or cirrhosis are signs of liver cancer.

Baby of hep B mother must be vaccinated, judge rules  -  Feb 27, 2008
National Post,A judge has ordered a mother with chronic hepatitis B to have her newborn baby vaccinated against the infectious disease, capping an unusual case that

FDA and Tibotec Dear Healthcare Professional Letter Regarding New ...  -  Mar 12, 2008
PharmaLive.com (press release),Increased AST/ALT monitoring should be considered in patients with underlying chronic hepatitis, cirrhosis, or in patients who have pretreatment elevations

Presidio Pharmaceuticals Obtains Exclusive Worldwide Rights to XTL ...  -  Mar 20, 2008
Earthtimes,HCV infection is a major cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Approximately 170 million people are infected with HCV

European CHMP Issues Positive Opinion for New Viread Use  -  Mar 20, 2008
FDA news (subscription),...issued a positive opinion on Gilead Sciencesâ€™ application to extend the indication for Viread to include the treatment of chronic hepatitis B in adults.

Form 4 Oracle: Boston, MA -- Form4Oracle: Insider Trading Report ...  -  Mar 14, 2008
Trading Markets (press release),The company developed Tyzeka/Sebivo through a co development agreement with Novartis Pharma AG for the treatment of patients with chronic hepatitis B in the

Indian doctor at centre of hepatitis scare in US  -  Mar 7, 2008
Times of India,The infection can cause liver inflammation that is often asymptomatic, but ensuing chronic hepatitis can result later in cirrhosis and liver cancer.

Serum fibrosis markers correlate with liver fibrosis stage in ...  -  Mar 3, 2008
HULIQ,A prospective study of patients with advanced chronic hepatitis C (CHC) revealed that a 3-variable model of serum fibrosis markers, including serum HA,

40000 Patients May Have Been Exposed to Hepatitis C  -  Feb 28, 2008
Today's SurgiCenter,Individuals with chronic hepatitis C virus and HIV infections typically are asymptomatic for many years and are often not aware they are infected.

Media Advisory - Understanding What's New And What's Hot In ...  -  Feb 28, 2008
Canada NewsWire (press release),Today, there are promising new treatment for people living with chronic hepatitis that can slow down liver damage caused by the virus.

Latest case undercuts Gibbonsâ€™ clinic defense  -  Mar 19, 2008
Las Vegas Sun,Most are â€œchronicâ€? hepatitis C cases, meaning there are no immediate symptoms. The number of positive hepatitis C tests has been â€œat the high end of the

Eltrombopag in Thrombocytopenia  -  Mar 5, 2008
New England Journal of Medicine (subscription),Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology 2002;123:1061-1069.

Liver Disease in Children  -  Mar 4, 2008
Journal of American Medical Association (subscription),The third section specifically reviews acute and chronic hepatitis; immune-mediated liver disorders, including autoimmune hepatitis and sclerosing

Pakistanâ€™s Khalid Mehmood Died of Liver Problems, No Foul Play ...  -  Mar 21, 2008
MedIndia,The internal inquiry by jail officials and magisterial probe have established that Khalid Mehmood alias Azad died due to chronic hepatitis and rupture of

Pak prisoner died of liver problems: Police  -  Mar 20, 2008
Times of India,..."The internal inquiry by jail officials and magisterial probe have established that Khalid Mehmood alias Azad died due to chronic hepatitis and rupture of

Scientists unite to fight disease  -  Mar 17, 2008
China Internet Information Center|,The vaccine has been tried on 242 chronic hepatitis B patients. An obvious drop in the key viral load was observed in 37.2 percent of the patients.

Docs risk infection to perform surgery  -  Mar 4, 2008
Times of India,It also leads to chronic hepatitis, cirrhosis and hepato-cellular carcinoma, which result in 1 million deaths annually worldwide.

Alcohol is just one of the causes of cirrhosis  -  Feb 25, 2008
The Star-Ledger - NJ.com,But the hepatitis C virus and the hepatitis B virus may cause chronic hepatitis, which progresses to cirrhosis years after the initial infection.

Biolex Announces Publication of Phase 1 Locteron Â® Results in the ...  -  Mar 11, 2008
Market Wire (press release)...a controlled-release interferon alfa in development for the treatment of chronic hepatitis C, in the Journal of Interferon & Cytokine Research.

Valeant Pharmaceuticals Reports Encouraging Phase IIb Results at ...  -  Mar 17, 2008
Business Wire (press release),...taribavirin, a prodrug of ribavirin in development for the treatment of chronic hepatitis C in conjunction with a pegylated interferon.

New HIV Drug Linked to Risk for Hepatitis  -  Mar 13, 2008
Medscape (subscription)More frequent monitoring of liver enzymes may be indicated for patients with underlying chronic hepatitis, cirrhosis, or baseline transaminase elevations.

Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant ...  -  Feb 28, 2008
FOXBusinessThe Company is developing ANA598, a small-molecule, non-nucleoside inhibitor of the NS5B polymerase for the treatment of chronic hepatitis C and ANA773,

OctoPlus announces publication of Phase I Locteron results in the ...  -  Mar 11, 2008
Ad-Hoc-News (Pressemitteilung),About LocteronLocteron is designed to be a best-in-class therapeutic for patientswith chronic hepatitis C, with the potential to reduce side effects,improve

OctoPlus Announces Publication Of Phase I Locteron Results In The ...  -  Mar 11, 2008
ABN Newswire (press release),About Locteron Locteron is designed to be a best-in-class therapeutic for patients with chronic hepatitis C, with the potential to reduce side effects,

Search the web for more resources on

Web health.mongabay.com

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.